Fresenius Medical Care

Type
Internal restructuring
Country
World
Region
Location of affected unit(s)
Germany, other locations
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.20 - Manufacture of pharmaceutical preparations
5,000 jobs
Number of planned job losses
Job loss
Announcement Date
17 November 2021
Employment effect (start)
17 November 2021
Foreseen end date

Description

German Pharmaceutical company Fresenius Medical Care (FMC) has announced that it will cut 5,000 jobs worldwide. So far, the company has announced that between 500 and 750 jobs are to be cut in Germany by the end of 2024. Job cuts are part of a €500 million cost saving programme. Fresenius Medical Care has been troubled by the pandemic for a long time since many people with chronic kidney disease die of the coronavirus, which reduces the number of treatments the company performs.

Fresenius Medical Care employed over 125,000 employees worldwide in 2020. It provides products and services for dialysis, in hospitals and in outpatient medical care.

Sources

Citation

Eurofound (2021), Fresenius Medical Care, Internal restructuring in World, factsheet number 106120, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/106120.